Fleseriu, Maria

Hormonal Replacement in Hypopituitarism in Adults: An Endocrine Society Clinical Practice Guideline

Fleseriu, M., Hashim, I. A., Karavitaki, N., Melmed, S., Murad, M. H., Salvatori, R., & Samuels, M. H. (2016) · The Journal of Clinical Endocrinology & Metabolism

Pituitary Gland Disorders and TreatmentsHormonal and reproductive studies

Cited by 945

Diagnosis and management of prolactin-secreting pituitary adenomas: a Pituitary Society International Consensus Statement

Petersenn, S., Fleseriu, M., Casanueva, F. F., Giustina, A., Biermasz, N., Biller, B. M. K., Bronstein, M., Chanson, P., Fukuoka, H., Gadelha, M., et al. (2023) · Nature Reviews Endocrinology

Pituitary Gland Disorders and TreatmentsNeuroendocrine Tumor Research Advances

Cited by 411

Efficacy and safety of osilodrostat in patients with Cushing's disease (LINC 3): a multicentre phase III study with a double-blind, randomised withdrawal phase

Pivonello, R., Fleseriu, M., Newell-Price, J., Bertagna, X., Findling, J., Shimatsu, A., Gu, F., Auchus, R., Leelawattana, R., Lee, E. J., et al. (2020) · The Lancet Diabetes & Endocrinology

Pituitary Gland Disorders and TreatmentsAdrenal Hormones and Disorders

Cited by 222

Remission rate after transsphenoidal surgery in patients with pathologically confirmed Cushing’s disease, the role of cortisol, ACTH assessment and immediate reoperation: a large single center experience

Hameed, N., Yedinak, C. G., Brzana, J., Gultekin, S. H., Coppa, N. D., Dogan, A., Delashaw, J. B., & Fleseriu, M. (2013) · Pituitary

Pituitary Gland Disorders and TreatmentsAdrenal and Paraganglionic Tumors

Cited by 102

Efficacy and safety of levoketoconazole in the treatment of endogenous Cushing's syndrome (SONICS): a phase 3, multicentre, open-label, single-arm trial

Fleseriu, M., Pivonello, R., Elenkova, A., Salvatori, R., Auchus, R. J., Feelders, R. A., Geer, E. B., Greenman, Y., Witek, P., Cohen, F., et al. (2019) · The Lancet Diabetes & Endocrinology

Pituitary Gland Disorders and TreatmentsAdrenal Hormones and Disorders

Cited by 101

Updates on the role of adrenal steroidogenesis inhibitors in Cushing’s syndrome: a focus on novel therapies

Fleseriu, M., & Castinetti, F. (2016) · Pituitary

Pituitary Gland Disorders and TreatmentsAdrenal and Paraganglionic Tumors

Cited by 87

American association of clinical endocrinologists and american college of endocrinology disease state clinical review: diagnosis of recurrence in Cushing disease

Fleseriu, M., Hamrahian, A. H., Hoffman, A. R., Kelly, D. F., & Katznelson, L. (2016) · Endocrine Practice

Pituitary Gland Disorders and TreatmentsAdrenal Hormones and Disorders

Cited by 68

Fracture risk in adult patients treated with growth hormone replacement therapy for growth hormone deficiency: a prospective observational cohort study

Mo, D., Fleseriu, M., Qi, R., Jia, N., Child, C. J., Bouillon, R., & Hardin, D. S. (2015) · The Lancet Diabetes & Endocrinology

Growth Hormone and Insulin-like Growth FactorsBone health and osteoporosis research

Cited by 64

Use of late-night salivary cortisol to monitor response to medical treatment in Cushing's disease

Newell-Price, J., Pivonello, R., Tabarin, A., Fleseriu, M., Witek, P., Gadelha, M. R., Petersenn, S., Tauchmanova, L., Ravichandran, S., Gupta, P., et al. (2020) · European Journal of Endocrinology

Pituitary Gland Disorders and TreatmentsAdrenal Hormones and Disorders

Cited by 60

Hypercortisolemia Recurrence in Cushing’s disease; a diagnostic challenge

Hinojosa-Amaya, J. M., Varlamov, E. V., McCartney, S., & Fleseriu, M. (2019) · Frontiers in Endocrinology

Pituitary Gland Disorders and TreatmentsAdrenal and Paraganglionic Tumors

Cited by 45

Recovery rate of adrenal function after surgery in patients with acromegaly is higher than in those with non-functioning pituitary tumors: a large single center study

Yedinak, C., Hameed, N., Gassner, M., Brzana, J., McCartney, S., & Fleseriu, M. (2015) · Pituitary

Pituitary Gland Disorders and TreatmentsAdrenal Hormones and Disorders

Cited by 27

Normal hypothalamic-pituitary-adrenal axis by high-dose cosyntropin testing in patients with abnormal response to low-dose cosyntropin stimulation: a retrospective review

Fleseriu, M., Gassner, M., Yedinak, C., Chicea, L., Delashaw, J. B., & Loriaux, D. L. (2010) · Endocrine Practice

Adrenal Hormones and DisordersStress Responses and Cortisol

Cited by 22

Improved clinical outcomes during long-term osilodrostat treatment of Cushing disease with normalization of late-night salivary cortisol and urinary free cortisol

Newell-Price, J., Fleseriu, M., Pivonello, R., Feelders, R. A., Gadelha, M. R., Lacroix, A., Witek, P., Heaney, A. P., Piacentini, A., Pedroncelli, A. M., et al. (2024) · Journal of the Endocrine Society

Pituitary Gland Disorders and TreatmentsAdrenal Hormones and Disorders

Cited by 21

The conundrum of differentiating Cushing’s syndrome from non-neoplastic hypercortisolism: a systematic review and meta-analysis

Hinojosa-Amaya, J. M., González-Colmenero, F. D., Alvarez-Villalobos, N. A., Salcido-Montenegro, A., Quintanilla-Sánchez, C., Moreno-Peña, P. J., Manzanares-Gallegos, D. M., Gutiérrez-Dávila, L. F., Castillo-Morales, P. L., García-Campa, M., et al. (2024) · Pituitary

Pituitary Gland Disorders and TreatmentsAdrenal Hormones and Disorders

Cited by 14

Mifepristone increases thyroid hormone requirements in patients with central hypothyroidism: a multicenter study

Guarda, F. J., Findling, J., Yuen, K. C. J., Fleseriu, M., & Nachtigall, L. B. (2019) · Journal of the Endocrine Society

Pituitary Gland Disorders and TreatmentsThyroid Disorders and Treatments

Cited by 12